Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 3

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 15
Chunk 3
---
.30
     
    06/29/2015

    10.13†
     
    Amendment No. 1 to the Exclusive License Agreement, by and between Atara Biotherapeutics, Inc. and Memorial Sloan Kettering Cancer Center, dated as of August 30, 2018
     
    10-K

    10.14
     
    02/26/2019

    10.14
     
    Office Lease, by and between BXP 611 Gateway Center LP and Atara Biotherapeutics, Inc., dated as of December 9, 2015
     
    10-K

    10.29
     
    03/04/2016

    10.15
     
    First Amendment to Lease, by and between BXP 611 Gateway Center LP and Atara Biotherapeutics, Inc., dated October 21, 2020
     
    10-Q

    10.4
     
    11/09/2020

    10.16
     
    Second Amendment to Lease, by and between Atara Biotherapeutics, Inc. and 611 Gateway Center LP, LLC, dated December 9, 2021
     
    10-K

    10.36
     
    02/28/2022

135

    Exhibit

    Incorporated by Reference
     
    Filed

    Number
     
    Exhibit Description
     
    Form

    Exhibit
     
    Filing Date
     
    Herewith

    10.17
     
    Standard Industrial Lease by and between Thousand Oaks Industrial Portfolio, LLC and Atara Biotherapeutics, Inc. dated February 6, 2017
     
    10-Q

    10.1
     
    05/04/2017

    10.18
     
    Lease Agreement between LA Region No. 2, LLC and Atara Biotherapeutics, Inc. dated March 17, 2021
     
    10-Q

    10.2
     
    05/04/2021

    10.19
     
    First Amended and Restated Exclusive License Agreement by and between Atara Biotherapeutics, Inc. and Memorial Sloan Kettering Cancer Center, dated March 22, 2021
     
    10-Q